Somnomed

Somnomed's mission is to set the global standard for outcomes, innovation, and patient experience in oral appliance therapy for Obstructive Sleep Apnea (OSA). The company has achieved market leadership by delivering over one million devices worldwide, capitalizing on the significant compliance limitations of the dominant CPAP therapy. Its strategy centers on continuous product innovation for comfort and efficacy, expanding its medical channel and payer coverage, and driving broader adoption of oral appliances as a first-line treatment option within the sleep medicine ecosystem.

Proprietary oral appliance platform centered on mandibular advancement, featuring the b-flex Comfort Liner for tooth-cradling comfort and a high-precision manufacturing process ensuring First Time Fit.

Somnomed competes primarily against CPAP giants (ResMed, Philips) by offering an alternative therapy, and directly against other oral appliance makers (e.g., ProSomnus) where it differentiates via global scale, a long track record, and proprietary comfort technologies like the b-flex Comfort Liner.